Ovizio
Company

Last deal

$52.65K
Local Amount - EUR 50K

Amount

Grant

Stage

01.01.2017

Date

2

all rounds

$8.6M

Total amount

date founded

Financing round

General

About Company
Ovizio develops digital holographic interferometric microscopy products for life sciences research and development.

Industry

Sector :

Subsector :

Also Known As

Ovizio Imaging Systems

founded date

01.01.2010

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Ovizio specializes in creating four-dimensional (4D) microscopic imaging devices and software based on digital holographic microscopy. Their product lineup includes oLine 4D, a versatile desktop device for research and diagnostics that requires no specific sample preparation and compensates for scratches or distortions on the sample support. They also offer iLine 4D, a multipurpose device for flow monitoring and direct monitoring of cell cultures in bioreactors. Additionally, their software, OsOne, enables visualization, analysis, and archiving of images captured by their imaging devices. Ovizio's technology is widely used by scientists in pharmaceutical and biotech research and development. With a focus on the Life Sciences Bio-Processing segment and the Life Sciences research and development market, Ovizio's microscopy technology provides automated cell-monitoring solutions for cell and gene therapy, vaccine industry, and various life sciences applications. Their label-free and non-invasive microscopes allow for three-dimensional, real-time imaging of living cells, providing reliable tracking of cell density, morphology, viability, viral infection kinetics, and cell activation status. Ovizio's advanced systems offer significant cost reduction and quality improvement, particularly in automated cell culture monitoring, analysis, and quality control.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Aurora Spectral Technologies

Aurora Spectral Technologies

Aurora Spectral Technologies develops micro-spectroscopy imaging systems for biological research.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sherwood, WI, USA

total rounds

3

total raised

$1.88M
Tomocube

Tomocube

Tomocube is a startup that provides 3D holographic microscopy for scientists and clinicians.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, 3D Technology, Health Care

Location

Daejeon, Jeong-dong, Daejeon, South Korea

total rounds

5

total raised

$22.74M
Amnis

Amnis

Amnis manufactures ImageStream, a platform combining microscopy and flow cytometry for drug discovery, research, and diagnostics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seattle, WA, USA

total rounds

4

total raised

$21.89M
Q3DM

Q3DM

Q3DM is a company that offers innovative products and services in high throughput microscopy, enabling drug discovery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

1

Financials

Funding Rounds
2
2

Number of Funding Rounds

$8.6M

Money Raised

Their latest funding was raised on 01.01.2017. Their latest investor New Science Ventures. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.2017
1
$52.65K
Local Amount - EUR 50K
16.11.2015
5
$8.55M
Local Amount - EUR 8M
New Science Ventures

New Science Ventures

New Science Ventures is a venture capital firm that invests in life sciences and information technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Venture Capital, Biotechnology

Location

New York, NY, USA

count Of Investments

73

count Of Exists

16
Qbic Fund

Qbic Fund

Qbic Fund is a venture capital firm that invests in spin-off companies of universities and research institutions.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Association

Location

Belgium, WI, USA

count Of Investments

38

count Of Exists

7
Theodorus III

Theodorus III

Theodorus is a fund that invests in early stage projects based on proprietary disruptive technologies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Financial Services, Venture Capital

count Of Investments

20

count Of Exists

1
Co-Investors
Investors
6
3

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
New Science Ventures

New Science Ventures

New Science Ventures is a venture capital firm that invests in life sciences and information technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Venture Capital, Biotechnology

Location

New York, NY, USA

count Of Investments

73

count Of Exists

16
Qbic Fund

Qbic Fund

Qbic Fund is a venture capital firm that invests in spin-off companies of universities and research institutions.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Association

Location

Belgium, WI, USA

count Of Investments

38

count Of Exists

7
Theodorus III

Theodorus III

Theodorus is a fund that invests in early stage projects based on proprietary disruptive technologies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Financial Services, Venture Capital

count Of Investments

20

count Of Exists

1

People

Founders
2
Philip Mathuis
Philip Mathuis

Philip Mathuis

Philip Mathuis is the Co-Founder and CEO at Trince.

current job

Trince
Trince

organization founded

1

Philip Mathuis

Serge Jooris
Serge Jooris

Serge Jooris

I am the Chief Technical Officer and the co-founder of Ovizio Imaging Systems. I have always been hooked on new technologies and innovation. That makes me a kind of passionate technology geek. What I especially love with innovation is how it can solve problems and simplify daily operations. This is exactly why we decided to launch Ovizio: we wanted to apply holographic microscopy to biopharmaceutical applications and provide a solution that would make the life of cell biologists easier. I completed my engineering degree in electro-mechanics at the Université Libre de Bruxelles (ULB) with a thesis on classification problems in multi-dimensional spaces. I conducted a research program on opto-digital image recognition by correlation. Over the following ten years, I occupied various management positions in IT and Software Development where I acquired experience in product development and scientific team management. Entrepreneur at heart, in the end I couldn't help but run my own venture. And in a way, I came back to my first love: digital imaging. Enthusiastic and direct, I usually like going straight to the point while always keeping a positive mindset.

current job

Ovizio
Ovizio

organization founded

1

Serge Jooris

Employee Profiles
5
Emilie Viey

Emilie Viey

Chief executive officer

Serge Jooris

Serge Jooris

Founder & CTO

Activity

Recent News
0